INDIANA, Pa., May 01, 2025 ( GLOBE NEWSWIRE ) -- First Commonwealth Financial Corporation ( NYSE: FCF ) ( "First Commonwealth" ) today announced that it has completed its previously announced acquisition of CenterGroup Financial, Inc. ( "CenterGroup" ) , the parent company of Milford, Ohio-based ...

LONDON, Ontario, May 01, 2025 ( GLOBE NEWSWIRE ) -- Aduro Clean Technologies Inc. ( "Aduro" or the "Company" ) ADUR ( CSE: ACT ) 9D5, a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into ...

NORWALK, Conn., May 01, 2025 ( GLOBE NEWSWIRE ) -- FactSet ( NYSE: FDS | NASDAQ: FDS ) , a global financial digital platform and enterprise solutions provider, today announced that its Board of Directors approved a 6% increase in the regular quarterly cash dividend of $1.04 per share to $1.10 ...

BioStem to Showcase its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Spring Meeting ...

Recognized in both pre-and post-approval pharmacovigilance operations Recognized in both pre-and post-approval pharmacovigilance operations ...

NESS ZIONA, Israel, May 01, 2025 ( GLOBE NEWSWIRE ) -- Sol-Gel Technologies Ltd. ( the "Company" ) SLGL, a clinical-stage dermatology company, today announced a reverse share split ( the "Reverse Split" ) of the Company's issued and outstanding ordinary shares, par value NIS 0.1 per share ( the ...

JUPITER, Fla., May 01, 2025 ( GLOBE NEWSWIRE ) -- Ligand Pharmaceuticals Incorporated ( Nasdaq: LGND ) today announced that its senior management team will participate in the following upcoming investor conferences: • H.C. Wainwright Royalty Company Conference ( Virtual ) .

TORONTO, May 01, 2025 ( GLOBE NEWSWIRE ) -- Inventus Mining Corp. ( TSXV: IVS ) ( "Inventus" or the "Company" ) is pleased to announce that it has signed a Memorandum of Understanding ( "MOU" ) with McEwen Mining ( "MUX" ) to evaluate its Stock Mill for processing of material extracted from ...

CONSHOHOCKEN, Pa., May 01, 2025 ( GLOBE NEWSWIRE ) -- Madrigal Pharmaceuticals, Inc. ( NASDAQ: MDGL ) , a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis ( MASH ) , today reports first-quarter 2025 financial results and ...

- Reported positive topline results from the Phase 3 VERITAC-2 trial that support global regulatory filings ...